That is the question seemingly unaddressed in the announcement. Reading between the lines 7 completed more than six months treatment and 2 more than 10 months.
Assuming that the 2 patients are not a subset on the 7, that means it appears 5 of 14 didn’t survive 6 months. If median survival is 5.5 months this suggests the median survival isn’t much longer with use of Amplia’s agent.
Cue the outrage from the true believers.
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-33
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
